Evoking potent RNAi response in cancer using novel 2’-OMe-phosphorodithioated modified siRNAs

ABSTRACT: Use of MePS2-modified siRNAs to target GRAM Domain Containing 1B (GRAMD1B), a novel protein in taxane resistance.

ORGANISM(S): Homo sapiens

PROVIDER: GSE54459 | GEO | 2014/03/10

SECONDARY ACCESSION(S): PRJNA236554

REPOSITORIES: GEO